Bajetta E - Search Results

1

Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: results of a feasibility study.

Bajetta E, Di Bartolomeo M, Stani SC, Artale S, Ricci SB, Bozzetti F, Mazzaferro V, Toffolatti L, Buzzoni R. Bajetta E, et al. Int J Radiat Oncol Biol Phys. 1999 Sep 1;45(2):285-9. doi: 10.1016/s0360-3016(99)00205-9. Int J Radiat Oncol Biol Phys. 1999. PMID: 10487547

2

Combined modality treatment for stage I-II non-Hodgkin's lymphomas: CVP versus BACOP chemotherapy.

Bajetta E, Valagussa P, Bonadonna G, Lattuada A, Buzzoni R, Rilke F, Banfi A. Bajetta E, et al. Int J Radiat Oncol Biol Phys. 1988 Jul;15(1):3-12. doi: 10.1016/0360-3016(88)90340-9. Int J Radiat Oncol Biol Phys. 1988. PMID: 2455701 Clinical Trial.

3

Doxifluridine: an active agent in advanced gastrointestinal cancer.

Di Bartolomeo M, Bajetta E, Somma L, Buzzoni R. Di Bartolomeo M, et al. Among authors: bajetta e. Tumori. 1995 May-Jun;81(3 Suppl):147-50. Tumori. 1995. PMID: 7571047 Clinical Trial.

4

Doxifluridine and leucovorin: an oral treatment combination in advanced colorectal cancer.

Bajetta E, Colleoni M, Di Bartolomeo M, Buzzoni R, Bozzetti F, Doci R, Somma L, Cappuzzo F, Stampino CG, Guenzi A, et al. Bajetta E, et al. J Clin Oncol. 1995 Oct;13(10):2613-9. doi: 10.1200/JCO.1995.13.10.2613. J Clin Oncol. 1995. PMID: 7595715 Clinical Trial.

5

Phase II study of the etoposide, leucovorin and fluorouracil combination for patients with advanced gastric cancer unsuitable for aggressive chemotherapy.

di Bartolomeo M, Bajetta E, de Braud F, Bochicchio AM, Gebbia V, Bozzetti F, Doci R, Bonfanti G, Cozzaglio L. di Bartolomeo M, et al. Among authors: bajetta e. Oncology. 1995 Jan-Feb;52(1):41-4. doi: 10.1159/000227425. Oncology. 1995. PMID: 7800341 Clinical Trial.

6

Doxifluridine as palliative treatment in advanced gastric and pancreatic cancer patients.

Di Bartolomeo M, Bajetta E, Somma L, Carnaghi C, Bandieri E, Del Vecchio M, Gallo Stampino C, Buzzoni R. Di Bartolomeo M, et al. Among authors: bajetta e. Oncology. 1996 Jan-Feb;53(1):54-7. doi: 10.1159/000227535. Oncology. 1996. PMID: 8570132 Clinical Trial.

7

Doxifluridine: previous experience and new developments in the treatment of colorectal cancer.

Bajetta E, Buzzoni R, Artale S, Di Bartolomeo M. Bajetta E, et al. Tumori. 1997 Jan-Feb;83(1 Suppl):S87-9. Tumori. 1997. PMID: 9154079 No abstract available.

8

Doxifluridine in colorectal cancer patients resistant to 5-fluorouracil (5-FU) containing regimens.

Bajetta E, Di Bartolomeo M, Somma L, Del Vecchio M, Artale S, Zunino F, Bignami P, Magnani E, Buzzoni R. Bajetta E, et al. Eur J Cancer. 1997 Apr;33(4):687-90. doi: 10.1016/s0959-8049(96)00491-1. Eur J Cancer. 1997. PMID: 9274455 Clinical Trial.

9

Oral doxifluridine plus levoleucovorin in elderly patients with advanced breast cancer.

Bajetta E, Biganzoli L, Carnaghi C, Di Bartolomeo M, Spagnoli I, Cassata A, Galante E, Mariani L, Stampino CG, Buzzoni R. Bajetta E, et al. Cancer. 1998 Sep 15;83(6):1136-41. doi: 10.1002/(sici)1097-0142(19980915)83:6<1136::aid-cncr12>3.0.co;2-6. Cancer. 1998. PMID: 9740078 Clinical Trial.

10

Integrated treatment with doxifluridine and radiotherapy in recurrent or primary unresectable rectal cancer. A feasibility study.

Di Bartolomeo M, Bajetta E, Buzzoni R, Bozzetti F, Artale S, Valvo F. Di Bartolomeo M, et al. Among authors: bajetta e. Tumori. 1999 May-Jun;85(3):211-3. doi: 10.1177/030089169908500313. Tumori. 1999. PMID: 10426135

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

354 results

Search Page

Filters